Zurcher Kantonalbank (Zurich Cantonalbank) Biotechnology

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
CPRX Catalyst Pharmaceuticals, Inc.	$2.34B	$498,000 0.0% of portfolio	25,080	Q3 2024 Added 1.57%
VCEL Vericel Corp	$2.79B	$481,000 0.0% of portfolio	11,399	Q4 2023 Added 34.49%
CLDX Celldex Therapeutics, Inc.	$1.11B	$479,000 0.0% of portfolio	14,111	Q2 2024 Added 40.86%
GERN Geron Corp	$1.09B	$476,000 0.0% of portfolio	104,924	Q2 2024 Added 7.27%
RYTM Rhythm Pharmaceuticals, Inc.	$3.21B	$476,000 0.0% of portfolio	9,101	Q3 2024 Reduced 0.09%
RCUS Arcus Biosciences, Inc.	$1.01B	$470,000 0.0% of portfolio	30,781	Q3 2024 Added 2.82%
AXSM Axsome Therapeutics, Inc.	$3.94B	$467,000 0.0% of portfolio	5,199	Q1 2024 Reduced 10.88%
PTGX Protagonist Therapeutics, Inc	$1.81B	$441,000 0.0% of portfolio	9,828	Q3 2024 Reduced 0.16%
ARDX Ardelyx, Inc.	$775M	$434,000 0.0% of portfolio	63,120	Q3 2024 Reduced 0.09%
MNKD Mannkind Corp	$1.55B	$415,000 0.0% of portfolio	66,144	Q2 2024 Reduced 0.02%
BCRX Biocryst Pharmaceuticals Inc	$1.39B	$387,000 0.0% of portfolio	51,012	Q3 2024 Added 7.71%
MIRM Mirum Pharmaceuticals, Inc.	$1.73B	$378,000 0.0% of portfolio	9,709	Q1 2024 Added 12.88%
ACAD Acadia Pharmaceuticals Inc	$2.84B	$368,000 0.0% of portfolio	23,964	Q3 2024 Reduced 0.04%
INVA Innoviva, Inc.	$1.3B	$353,000 0.0% of portfolio	18,300	Q3 2024 Reduced 1.19%
KURA Kura Oncology, Inc.	$486M	$352,000 0.0% of portfolio	18,060	Q2 2024 Added 34.72%
RXRX Recursion Pharmaceuticals, Inc.	$1.18B	$346,000 0.0% of portfolio	52,530	Q3 2024 Added 5.35%
RCKT Rocket Pharmaceuticals, Inc.	$780M	$346,000 0.0% of portfolio	18,767	Q3 2024 Added 9.8%
NRIX Nurix Therapeutics, Inc.	$902M	$340,000 0.0% of portfolio	15,168	Q3 2024 Reduced 0.26%
DYN Dyne Therapeutics, Inc.	$731M	$335,000 0.0% of portfolio	9,333	Q3 2024 Reduced 0.22%
VERA Vera Therapeutics, Inc.	$902M	$332,000 0.0% of portfolio	7,527	Q2 2024 Added 30.0%
VRDN Viridian Therapeutics, Inc.\De	$723M	$318,000 0.0% of portfolio	13,997	Q3 2024 Added 17.02%
KROS Keros Therapeutics, Inc.	$280M	$311,000 0.0% of portfolio	5,371	Q3 2024 Added 59.05%
SWTX Spring Works Therapeutics, Inc.	$2.16B	$292,000 0.0% of portfolio	9,124	Q2 2024 Reduced 0.16%
XNCR Xencor Inc	$1.15B	$285,000 0.0% of portfolio	14,215	Q2 2024 Reduced 50.0%
TVTX Travere Therapeutics, Inc.	$1.18B	$279,000 0.0% of portfolio	19,969	Q3 2024 Added 20.94%
OCUL Ocular Therapeutix, Inc	$617M	$278,000 0.0% of portfolio	31,981	Q3 2024 Reduced 0.2%
WVE Wave Life Sciences Ltd.	$978M	$274,000 0.0% of portfolio	33,491	Q2 2024 Added 75.16%
LBPH Longboard Pharmaceuticals, Inc.	$815M	$258,000 0.0% of portfolio	7,744	Q3 2024 Added 64.21%
ARVN Arvinas, Inc.	$960M	$247,000 0.0% of portfolio	10,062	Q2 2024 Added 30.69%
LGND Ligand Pharmaceuticals Inc	$1.89B	$240,000 0.0% of portfolio	2,399	Q2 2024 Reduced 0.04%
SNDX Syndax Pharmaceuticals Inc	$740M	$235,000 0.0% of portfolio	12,220	Q3 2024 Reduced 0.12%
AKRO Akero Therapeutics, Inc.	$1.17B	$225,000 0.0% of portfolio	7,845	Q2 2024 Reduced 0.01%
SAVA Cassava Sciences Inc	$110M	$219,000 0.0% of portfolio	7,467	Q1 2024 Added 32.37%
IMVT Immunovant, Inc.	$3.55B	$218,000 0.0% of portfolio	7,925	Q2 2024 Reduced 0.06%
EWTX Edgewise Therapeutics, Inc.	$1.66B	$217,000 0.0% of portfolio	8,161	Q3 2024 Reduced 0.44%
MRVI Maravai Lifesciences Holdings, Inc.	$627M	$211,000 0.0% of portfolio	25,450	Q2 2024 Added 32.29%
AUPH Aurinia Pharmaceuticals Inc.	$1.14B	$209,000 0.0% of portfolio	28,634	Q4 2023 Added 9.11%
HRMY Harmony Biosciences Holdings, Inc.	$2.31B	$205,000 0.0% of portfolio	5,149	Q2 2024 Reduced 29.56%
COGT Cogent Biosciences, Inc.	$528M	$204,000 0.0% of portfolio	18,934	Q4 2023 Added 67.14%
ARCT Arcturus Therapeutics Holdings Inc.	$446M	$201,000 0.0% of portfolio	8,694	Q3 2024 Added 10.78%
TARS Tarsus Pharmaceuticals, Inc.	$1.24B	$199,000 0.0% of portfolio	6,075	Q3 2024 Reduced 0.56%
MDXG Mimedx Group, Inc.	$1.04B	$198,000 0.0% of portfolio	33,623	Q1 2024 Added 11.83%
VIR Vir Biotechnology, Inc.	$1.34B	$188,000 0.0% of portfolio	25,231	Q3 2024 Added 2.37%
LQDA Liquidia Corp	$810M	$187,000 0.0% of portfolio	18,708	Q3 2024 Added 43.48%
SVRA Savara Inc	$317M	$186,000 0.0% of portfolio	44,008	Q2 2024 Added 967.64%
PHAT Phathom Pharmaceuticals, Inc.	$273M	$182,000 0.0% of portfolio	10,071	Q2 2024 Added 42.17%
ARQT Arcutis Biotherapeutics, Inc.	$763M	$174,000 0.0% of portfolio	18,762	Q2 2024 New
PRTA Prothena Corp Public LTD CO	$646M	$171,000 0.0% of portfolio	10,236	Q2 2024 Added 13.1%
JANX Janux Therapeutics, Inc.	$1.7B	$163,000 0.0% of portfolio	3,609	Q2 2024 New
CDMO Avid Bioservices, Inc.	$770M	$156,000 0.0% of portfolio	13,741	Q2 2024 Added 28.42%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.